Unresectable Extrahepatic Bile Duct Cancer Terminated Phase 2 Trials for Ixabepilone (DB04845)

IndicationStatusPhase
DBCOND0028791 (Unresectable Extrahepatic Bile Duct Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00023946BMS-247550 in Treating Patients With Liver or Gallbladder CancerTreatment